Bilateral injections of amyloid-β 25-35 into the amygdala of young Fischer rats: Behavioral, neurochemical, and time dependent histopathological effects

Neurobiology of Aging

Volumn 18, Issue 6, 1997, Pages 591-608

  Sigurdsson, E M ^a   Lee, J M ^a   Dong, X W ^a   Hejna, M J ^a   Lorens, S A ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid protein; Animal model; Behavior; GFAP; Interleukin 1 ; Tau protein; Time course

Indexed keywords

AMYLOID BETA PROTEIN; INTERLEUKIN 1; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; CONTROLLED STUDY; HIPPOCAMPUS; HISTOPATHOLOGY; INJECTION SITE; INTRAVENOUS DRUG ADMINISTRATION; LEFT HEMISPHERE; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; RIGHT HEMISPHERE; SENILE PLAQUE;

AMYGDALA; AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CONGO RED; GLIAL FIBRILLARY ACIDIC PROTEIN; HISTOCYTOCHEMISTRY; INTERLEUKIN-1; MALE; OXAZINES; PEPTIDE FRAGMENTS; RATS; RATS, INBRED F344; TAU PROTEINS; TIME FACTORS;

EID: 0031457782     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(97)00154-1     Document Type: Article

References (157)

1. Aggleton J. P., Blindt H. S., Rawlins J. N. Effects of amygdaloid and amygdaloid-hippocampal lesions on object recognition and spatial working memory in rats. Behav. Neurosci. 103:1989;962-974.
2. Araujo D. M., Cotman C. W. β-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 569:1992;141-145.
3. Ard M. D., Cole G. M., Wei J., Mehrle A. P., Fratkin J. D. Scavenging of Alzheimer's amyloid β-protein by microglia in culture. J. Neurosci. Res. 43:1996;190-202.
4. Arriagada P. V., Growdon J. H., Hedley-Whyte E. T., Hyman B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
5. Auron P. E., Webb A. C., Rosenwasser L. J., Mucci S. F., Rich A., Wolff S. M., Dinarello C. A. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc. Natl. Acad. Sci. USA. 81:1984;7907-7911.
6. Barneoud P., Le Moal M., Neveu P. J. Asymmetrical effects of cortical ablation on brain monoamines in mice. Int. J. Neurosci. 56:1991;283-294.
7. Belcheva I., Belcheva S., Petkov V. V., Petkov V. D. Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala. Neuropharmacology. 33:1994;995-1002.
8. Buee L., Laine A., Delacourte A., Flament S., Han K. K. Qualitative and quantitative comparison of brain proteins in Alzheimer's disease. Biol. Chem. Hoppe-Seyler. 370:1989;1229-1234.
9. Burger P. C., Vogel F. S. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am. J. Pathol. 73:1973;457-476.
10. Busciglio J., Lorenzo A., Yankner B. A. Methodological variables in the assessment of β amyloid neurotoxicity. Neurobiol. Aging. 13:1992;609-612.
11. Busciglio J., Lorenzo A., Yeh J., Yankner B. A. β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:1995;879-888.
12. Bush D. F., Lovely R. H., Pagano R. R. Injection of ACTH induces recovery from shuttle-box avoidance deficits in rats with amygdaloid lesions. J. Comp. Physiol. Psychol. 83:1973;168-172.
13. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffe E. A., Gandy S. E., Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA. 89:1992;10075-10078.
14. Cai X. D., Golde T. E., Younkin S. G. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science. 259:1993;514-516.
15. Canning D. R., McKeon R. J., DeWitt D. A., Perry G., Wujek J. R., Frederickson R. C., Silver J. β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp. Neurol. 124:1993;289-298.
16. Carlsen J., Zaborszky L., Heimer L. Cholinergic projections from the basal forebrain to the basolateral amygdaloid complex A combined retrograde fluorescent and immunohistochemical study . J. Comp. Neurol. 234:1985;155-167.
17. Carlson J. N., Visker K. E., Keller R. W., Glick S. D. Left and right 6-hydroxydopamine lesions of the medial prefrontal cortex differentially alter subcortical dopamine utilization and the behavioral response to stress. Brain Res. 711:1996;1-9.
18. Chase T. N., Foster N. L., Fedio P., Brooks R., Mansi L., Di Chiro G. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography. Ann. Neurol. 15:(Suppl.):1984;S170-S174.
19. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P., Lieberburg I., Selkoe D. J. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature. 360:1992;672-674.
20. Clark B. D., Collins K. L., Gandy M. S., Webb A. C., Auron P. E. Genomic sequence for human prointerleukin 1β Possible evolution from a reverse transcribed prointerleukin 1α gene (published erratum appears in Nucleic Acids Res. 15:868; 1987) . Nucleic Acids Res. 14:1986;7897-7914.
21. Cleary J., Hittner J. M., Semotuk M., Mantyh P., O'Hare E. β-amyloid(1-40) effects on behavior and memory. Brain Res. 682:1995;69-74.
22. Clemens J. A., Stephenson D. T. Implants containing β-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol. Aging. 13:1992;581-586.
23. Coleman-Mesches K., McGaugh J. L. Muscimol injected into the right or left amygdaloid complex differentially affects retention performance following aversively motivated training. Brain Res. 676:1995;183-188.
24. Coleman-Mesches K., McGaugh J. L. Differential involvement of the right and left amygdalae in expression of memory for aversively motivated training. Brain Res. 670:1995;75-81.
25. Coleman-Mesches K., McGaugh J. L. Differential effects of pretraining inactivation of the right or left amygdala on retention of inhibitory avoidance training. Behav. Neurosci. 109:1995;642-647.
26. Corman C. D., Meyer P. M., Meyer D. R. Open-field activity and exploration in rats with septal and amygdaloid lesions. Brain Res. 5:1967;469-476.
27. Crystal H. A., Horoupian D. S., Katzman R., Jotkowitz S. Biopsy-proved Alzheimer's disease presenting as a right parietal lobe syndrome. Ann. Neurol. 12:1981;186-188.
28. Decker M. W., Curzon P., Brioni J. D. Influence of separate and combined septal and amygdala lesions on memory, acoustic startle, anxiety, and locomotor activity in rats. Neurobiol. Learn. Mem. 64:1995;156-168.
29. Del Bo R., Angeretti N., Lucca E., De Simoni M. G., Forloni G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures. Neurosci. Lett. 188:1995;70-74.
30. Delacourte A. General and dramatic glial reaction in Alzheimer brains. Neurology. 40:1990;33-37.
31. Dewberry R. G., Lipsey J. R., Saad K., Moran T. H., Robinson R. G. Lateralized response to cortical injury in the rat Interhemispheric interaction . Behav. Neurosci. 100:1986;556-562.
32. Dickson D. W., Lee S. C., Mattiace L. A., Yen S. H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. GLIA. 7:1993;75-83.
33. Dinarello C. A. Interleukin-1 and Interleukin-1 antagonism. Blood. 77:1991;1627-1652.
34. Donnelly R. J., Friedhoff A. J., Beer B., Blume A. J., Vitek M. P. Interleukin-1 stimulates the β-amyloid precursor protein promoter. Cell Mol. Neurobiol. 10:1990;485-495.
35. Dornan W. A., Kang D. E., McCampbell A., Kang E. E. Bilateral injections of βA(25-35) + IBO into the hippocampus disrupts acquisition of spatial learning in the rat. Neuroreport. 5:1993;165-168.
36. Duara R., Grady C., Haxby J., Sundaram M., Cutler N. R., Heston L., Moore A., Larson S., Rapoport S. I. Positron emission tomography in Alzheimer's disease. Neurology. 36:1986;879-887.
37. Duffy P. E., Rapport M., Graf L. Glial fibrillary acidic protein and Alzheimer-type senile dementia. Neurology. 30:1980;778-782.
38. Eclancher F., Karli P. Effects of early amygdaloid lesions on the development of reactivity in the rat. Physiol. Behav. 22:1979;123-134.
39. Eng L. F., Vanderhaeghen J. J., Bignami A., Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res. 28:1971;351-354.
40. Fagarasan M. O., Aisen P. S. IL-1 and anti-inflammatory drugs modulate Aβ cytotoxicity in PC12 cells. Brain Res. 723:1996;231-234.
41. Flood J. F., Morley J. E., Roberts E. Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 88:1991;3363-3366.
42. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24:1975;407-409.
43. Forloni, G.; Demicheli, F.; Giorgi, S.; Bendotti, C.; Angeretti, N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: Modulation by interleukin-1. Brain Res. Mol. Brain Res. 128-134; 1992.
44. Frautschy S. A., Baird A., Cole G. M. Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA. 88:1991;8362-8366.
45. Frautschy S. A., Yang F. S., Calderon L., Cole G. M. Rodent models of Alzheimer's disease Rat Aβ infusion approaches to amyloid deposits . Neurobiol. Aging. 17:1996;311-321.
46. Friedland R. P., Budinger T. F., Koss E., Ober B. A. Alzheimer's disease Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization . Neurosci. Lett. 53:1985;235-240.
47. Furutani, Y.; Notake, M.; Fukui, T.; Ohue, M.; Nomura, H.; Yamada, M.; Nakamura; S. Complete nucleotide sequence of the gene for human interleukin 1 alpha (published erratum appears in Nucleic Acids Res. 14:5124; 1986).
48. Furutani, Y.; Notake, M.; Fukui, T.; Ohue, M.; Nomura, H.; Yamada, M.; Nakamura; S. Complete nucleotide sequence of the gene for human interleukin 1 alpha (published erratum appears in Nucleic Acids Res. 14:5124; 1986). Nucleic Acids Res. 14:3167-3179; 1986.
49. Games D., Khan K. M., Soriano F. G., Keim P. S., Davis D. L., Bryant K. Lack of Alzheimer pathology after β-amyloid protein injections in rat brain. Neurobiol. Aging. 13:1992;569-576.
50. Giaccone G., Tagliavini F., Linoli G., Bouras C., Frigerio L., Frangione B., Bugiani O. Down patients Extracellular preamyloid deposits precede neuritic degeneration and senile plaques . Neurosci. Lett. 97:1989;232-238.
51. Giordano T., Pan J. B., Monteggia L. M., Holzman T. F., Snyder S. W., Krafft G., Kowall N. W. Similarities between beta amyloid peptides 1-40 and 40-1 Effects on aggregation, toxicity in vitro, and injection in young and aged rats . Exp. Neurol. 125:1994;175-182.
52. Giovannelli L., Casamenti F., Scali C., Bartolini L., Pepeu G. Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience. 66:1995;781-792.
53. Glenner G. G., Wong C. W. Alzheimer's disease Initial report of the purification and characterization of a novel cerebrovascular amyloid protein . Biochem. Biophys. Res. Commun. 120:1984;885-890.
54. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., Fidani L., Haynes A., Irving N., James L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease . Nature. 349:1991;704-706.
55. Goldgaber D., Harris H. W., Hla T., Maciag T., Donnelly R. J., Jacobsen J. S., Vitek M. P., Gajdusek D. C. Interleukin-1 regulates synthesis of amyloid β protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA. 86:1989;7606-7610.
56. Grady C. L., Haxby J. V., Schlageter N. L., Berg G., Rapoport S. I. Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type. Neurology. 36:1986;1390-1392.
57. Griffin W. S., Sheng J. G., Roberts G. W., Mrak R. E. Interleukin-1 expression in different plaque types in Alzheimer's disease Significance in plaque evolution . J. Neuropathol. Exp. Neurol. 54:1995;276-281.
58. Grijalva C. V., Levin E. D., Morgan M., Roland B., Martin F. C. Contrasting effects of centromedial and basolateral amygdaloid lesions on stress-related responses in the rat. Physiol. Behav. 48:1990;495-500.
59. Hachinski V. C., Oppenheimer S. M., Wilson J. X., Guiraudon C., Cechetto D. F. Asymmetry of sympathetic consequences of experimental stroke. Arch. Neurol. 49:1992;697-702.
60. Haga S., Akai K., Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol. 77:1989;569-575.
61. Hansen L. A., Armstrong D. M., Terry R. D. An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex. Neurobiol. Aging. 8:1987;1-6.
62. Hatten M. E., Liem R. K., Shelanski M. L., Mason C. A. Astroglia in CNS injury. GLIA. 4:1991;233-243.
63. Haxby J. V., Duara R., Grady C. L., Cutler N. R., Rapoport S. I. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J. Cereb. Blood Flow Metab. 5:1985;193-200.
64. Haxby J. V., Grady C. L., Duara R., Schlageter N., Berg G., Rapoport S. I. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Arch. Neurol. 43:1986;882-885.
65. Haxby J. V., Grady C. L., Friedland R. P., Rapoport S. I. Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early dementia of the Alzheimer type Longitudinal confirmation . J. Neural Transm. Suppl. 24:1987;49-53.
66. Haxby J. V., Grady C. L., Koss E., Horwitz B., Heston L., Schapiro M., Rapoport S. I. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch. Neurol. 47:1990;753-760.
67. Heffner T. G., Hartman J. A., Seiden L. S. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13:1980;453-456.
68. Hoke A., Canning D. R., Malemud C. J., Silver J. Regional differences in reactive gliosis induced by substrate-bound β-amyloid. Exp. Neurol. 130:1994;56-66.
69. Howlett D. R., Jennings K. H., Lee D. C., Clark M. S., Brown F., Wetzel R., Wood S. J., Camilleri P., Roberts G. W. Aggregation state and neurotoxic properties of Alzheimer β-amyloid peptide. Neurodegeneration. 4:1995;23-32.
70. Ichimiya A., Herholz K., Mielke R., Kessler J., Slansky I., Heiss W. D. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type A factor analytic study . J. Neurol. Sci. 123:1994;11-17.
71. Inestrosa N. C., Alvarez A., Perez C. A., Moreno R. D., Vicente M., Linker C., Soto C., Garrido J. Acetylcholinesterase accelerates assembly of amyloid-β peptides into Alzheimer's fibrils Possible role of the peripheral site of the enzyme . Neuron. 16:1996;881-891.
72. Itagaki S., Mcgeer P. L., Akiyama H., Zhu S., Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24:1989;173-182.
73. Jamada M., Mehraein P. Distribution of senile changes in the brain. The part of the limbic system in Alzheimer's disase and senile dementia (in German). Arch. Psychiatr. Nervenkrankheiten. 211:1968;308-324.
74. Jellestad F. K., Garcia Cabrera I. Exploration and avoidance learning after ibotenic acid and radio frequency lesions in the rat amygdala. Behav. Neural Biol. 46:1986;196-215.
75. Jellestad F. K., Markowska A., Bakke H. K., Walther B. Behavioral effects after ibotenic acid, 6-OHDA and electrolytic lesions in the central amygdala nucleus of the rat. Physiol. Behav. 37:1986;855-862.
76. Jonason K. R., Enloe L. J. Alterations in social behavior following septal and amygdaloid lesions in the rat. J. Comp. Physiol. Psychol. 75:1971;286-301.
77. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
78. Kidd M. Alzheimer's disease. An electron microscopical study. Brain. 87:1964;307-320.
79. Kondo J., Honda T., Mori H., Hamada Y., Miura R., Ogawara M., Ihara Y. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron. 1:1988;827-834.
80. Kowall N. W., Beal M. F., Busciglio J., Duffy L. K., Yankner B. A. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA. 88:1991;7247-7251.
81. Kowall N. W., McKee A. C., Yankner B. A., Beal M. F. In vivo neurotoxicity of β-amyloid [β (1-40)) and the β (25-35) fragment. Neurobiol. Aging. 13:1992;537-542.
82. Kromer Vogt L. J., Hyman B. T., Van Hoesen G. W., Damasio A. R. Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience. 37:1990;377-385.
83. Ksiezak-Reding H., Chien C. H., Lee V. M., Yen S. H. Mapping of the Alz 50 epitope in microtubule-associated proteins tau. J. Neurosci. Res. 25:1990;412-419.
84. Kubos K. L., Pearlson G. D., Robinson R. G. Intracortical kainic acid induces an asymmetrical behavioral response in the rat. Brain Res. 239:1982;303-309.
85. Lai F., Williams R. S. A prospective study of Alzheimer disease in Down syndrome. Arch. Neurol. 46:1989;849-853.
86. Loewenstein D. A., Barker W. W., Chang J. Y., Apicella A., Yoshii F., Kothari P., Duara R. Predominant left hemisphere metabolic dysfunction in dementia. Arch. Neurol. 46:1989;146-152.
87. Lomedico P. T., Gubler U., Hellmann C. P., Dukovich M., Giri J. G., Pan Y. C., Collier K., Semionow R., Chua A. O., Mizel S. B. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature. 312:1984;458-462.
88. Lorenzo A., Yankner B. A. β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA. 91:1994;12243-12247.
89. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-267.
90. Malouf A. T. Effect of beta amyloid peptides on neurons in hippocampal slice cultures. Neurobiol. Aging. 13:1992;543-551.
91. Mann D. M., Yates P. O., Marcyniuk B., Ravindra C. R. The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol. Appl. Neurobiol. 12:1986;447-457.
92. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
93. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
94. Mattson M. P., Tomaselli K. J., Rydel R. E. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621:1993;35-49.
95. Maurice T., Lockhart B. P., Privat A. Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction. Brain Res. 706:1996;181-193.
96. McDonald M. P., Dahl E. E., Overmier J. B., Mantyh P., Cleary J. Effects of an exogenous β-amyloid peptide on retention for spatial learning. Behav. Neural. Biol. 62:1994;60-67.
97. McDonald M. P., Overmier J. B., Bandyopadhyay S., Babcock D., Cleary J. Reversal of β-amyloid-induced retention deficit after exposure to training and state cues. Neurobiol. Learn Mem. 65:1996;35-47.
98. McGeer P. L., Kawamata T., Walker D. G., Akiyama H., Tooyama I., McGeer E. G. Microglia in degenerative neurological disease. GLIA. 7:1993;84-92.
99. McGeer P. L., Rogers J., McGeer E. G. Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alzheimer's Dis. Assoc. Disord. 8:1994;149-158.
100. Miller D. L., Papayannopoulos I. A., Styles J., Bobin S. A., Lin Y. Y., Biemann K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301:1993;41-52.
101. Moossy J., Zubenko G. S., Martinez A. J., Rao G. R., Kopp U., Hanin I. Lateralization of brain morphologic and cholinergic abnormalities in Alzheimer's disease. Arch. Neurol. 46:1989;639-642.
102. Motomura N., Seo T. Lateral hemispheric asymmetries in senile dementia of Alzheimer's type (SDAT) assessed by I-123 IMP SPECT imaging A preliminary report . Int J. Neurosci. 63:1992;1-3.
103. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet. 1:1992;345-347.
104. Nabeshima T., Nitta A. Memory impairment and neuronal dysfunction induced by β-amyloid protein in rats. Tohoku J. Exp. Med. 174:1994;241-249.
105. Naugle R. I., Cullum C. M., Bigler E. D., Massman P. J. Neuropsychological and computerized axial tomography volume characteristics of empirically derived dementia subgroups. J. Nerv. Ment. Dis. 173:1985;596-604.
106. Neve R. L., Finch E. A., Dawes L. R. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron. 1:1988;669-677.
107. Neveu P. J. Brain lateralization and immunomodulation. Int. J. Neurosci. 70:1993;135-143.
108. Nieto-Sampedro M. Astrocyte mitogenic activity in aged normal and Alzheimer's human brain. Neurobiol. Aging. 8:1987;249-252.
109. Nordstedt C., Naslund J., Tjernberg L. O., Karlstrom A. R., Thyberg J. The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils. J. Biol. Chem. 269:1994;30773-30776.
110. O'Brien J. T., Eagger S., Syed G. M., Sahakian B. J., Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 55:1992;1182-1187.
111. O'Callaghan J. P., Jensen K. F. Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity. Neurotoxicology. 13:1992;113-122.
112. O'Callaghan J. P., Miller D. B. Quantification of reactive gliosis as an approach to neurotoxicity assessment. NIDA Res. Monogr. 136:1993;188-212.
113. Olton D. S., Walker J. A., Gage F. H. Hippocampal connections and spatial discrimination. Brain Res. 139:1978;295-308.
114. Palmer A. M., Procter A. W., Stratmann G. C., Bowen D. M. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease. Neurosci. Lett. 66:1986;199-204.
115. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, San Diego, CA.
116. Pearlson G. D., Robinson R. G. Suction lesions of the frontal cerebral cortex in the rat induce asymmetrical behavioral and catecholaminergic responses. Brain Res. 218:1981;233-242.
117. Pearson R. C. A., Powell T. P. S. The neuroanatomy of Alzheimer's disease. Rev. Neurosci. 2:1989;101-122.
118. Peinado-Manzano M. A. The role of the amygdala and the hippocampus in working memory for spatial and non-spatial information. Behav. Brain Res. 38:1990;117-134.
119. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., Cotman C. W. Neurodegeneration induced by β-amyloid peptides in vitro The role of peptide assembly state . J. Neurosci. 13:1993;1676-1687.
120. Pike C. J., Cummings B. J., Cotman C. W. Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp. Neurol. 132:1995;172-179.
121. Pike C. J., Cummings B. J., Monzavi R., Cotman C. W. β-amyloid induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience. 63:1994;517-531.
122. Pike C. J., Walencewicz A. J., Glabe C. G., Cotman C. W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
123. Rawlins J. N., Olton D. S. The septo-hippocampal system and cognitive mapping. Behav. Brain Res. 5:1982;331-358.
124. Robinson R. G. Differential behavioral and biochemical effects of right and left hemispheric cerebral infarction in the rat. Science. 205:1979;707-710.
125. Roher A. E., Ball M. J., Bhave S. V., Wakade A. R. β-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. Biochem. Biophys. Res. Comm. 174:1991;572-579.
126. Roher A. E., Lowenson J. D., Clarke S., Wolkow C., Wang R., Cotter R. J., Zurcher-Neely H. A., Heinrikson R. L., Ball M. J., et al. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268:1993;3072-3083.
127. Roozendaal B., Koolhaas J. M., Bohus B. The central amygdala is involved in conditioning but not in retention of active and passive shock avoidance in male rats. Behav. Neural Biol. 59:1993;143-149.
128. Rossor M. N., Garrett N. J., Johnson A. L., Mountjoy C. Q., Roth M., Iversen L. L. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain. 105:1982;313-330.
129. Rossor M. N., Iversen L. L., Reynolds G. P., Mountjoy C. Q., Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br. Med. J. Clin. Res. Ed. 288:1984;961-964.
130. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Montgomery P., Beyreuther K., Masters C. L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. New Engl. J. Med. 320:1989;1446-1452.
131. Schobitz B., De Kloet E. R., Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol. 44:1994;397-432.
132. Schubert D. The possible role of adhesion in synaptic modification. Trends Neurosci. 14:1991;127-130.
133. Schwartzbaum J. S., Gay P. E. Interacting behavioral effects of septal and amygdaloid lesions in the rat. J. Comp Physiol. Psychol. 61:1966;59-65.
134. Seltzer B., Sherwin I. A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two? Arch. Neurol. 40:1983;143-146.
135. Sheng J. G., Mrak R. E., Griffin W. S. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease Correlation with neuritic plaque distribution . Neuropathol. Appl. Neurobiol. 21:1995;290-301.
136. Sigurdsson E. M., Hejna M. J., Lee J. M., Lorens S. A. β-amyloid 25-35 and/or quinolinic acid injections into the basal forebrain of young male Fischer-344 rats Behavioral, neurochemical and histological effects . Behav. Brain Res. 72:1995;141-156.
137. Sigurdsson E. M., Lee J. M., Dong X.-W., Hejna M. J., Lorens S. A. Laterality in the histological effects of injections of amyloid-β 25-35 into the amygdala of young Fischer rats. J. Neuropathol. Exp. Neurol. 56:1997;714-726.
138. Sigurdsson E. M., Lorens S. A., Hejna M. J., Dong X.-W., Lee J. M. Local and distant histopathological effects of unilateral amyloid-β 25-35 injections into the amygdala of young F344 rats. Neurobiol. Aging. 17:1996;893-901.
139. Smyth M. D., Kesslak J. P., Cummings B. J., Cotman C. W. Analysis of brain injury following intrahippocampal administration of β-amyloid in streptozotocin-treated rats. Neurobiol. Aging. 15:1994;153-159.
140. Snow A. D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Schreier W. A., Morgan D. G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain. Neuron. 12:1994;219-234.
141. Strijbos P. J., Rothwell N. J. Interleukin-1β attenuates excitatory amino acid-induced neurodegeneration in vitro Involvement of nerve growth factor . J. Neurosci. 15:1995;3468-3474.
142. Sullivan R. M., Szechtman H. Left/right nigrostriatal asymmetry in susceptibility to neurotoxic dopamine depletion with 6-hydroxydopamine in rats. Neurosci. Lett. 170:1994;83-86.
143. Sutherland R. J., McDonald R. J. Hippocampus, amygdala, and memory deficits in rats. Behav. Brain Res. 37:1990;57-79.
144. Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L. Jr, Eckman C., Golde T. E., Younkin S. G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 264:1994;1336-1340.
145. Tate B., Aboody-Guterman K. S., Morris A. M., Walcott E. C., Majocha R. E., Marotta C. A. Disruption of circadian regulation by brain grafts that overexpress Alzheimer β/A4 amyloid. Proc. Natl. Acad. Sci. USA. 89:1992;7090-7094.
146. Terry R. D. The fine structure of neurofibrillary tangles in Alzheimer's disease. J. Neuropathol Exp. Neurol. 22:1963;629-642.
147. Vereecken T. H., Vogels O. J., Nieuwenhuys R. Neuron loss and shrinkage in the amygdala in Alzheimer's disease. Neurobiol. Aging. 15:1994;45-54.
148. Vlajkovic S., Nikolic V., Nikolic A., Milanovic S., Jankovic B. D. Asymmetrical modulation of immune reactivity in left- and right-biased rats after ipsilateral ablation of the prefrontal, parietal and occipital brain neocortex. Int. J. Neurosci. 78:1994;123-134.
149. Werka T., Skar J., Ursin H. Exploration and avoidance in rats with lesions in amygdala and piriform cortex. J. Comp. Physiol. Psychol. 92:1978;672-681.
150. Winkler J., Connor D. J., Frautschy S. A., Behl C., Waite J. J., Cole G. M., Thal L. J. Lack of long-term effects after β-amyloid protein injections in rat brain. Neurobiol. Aging. 15:1994;601-607.
151. Wischik C. M., Novak M., Edwards P. C., Klug A., Tichelaar W., Crowther R. A. Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 85:1988;4884-4888.
152. Wischik C. M., Novak M., Thogersen H. C., Edwards P. C., Runswick M. J., Jakes R., Milstein C., Roth M., Klug A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 85:1988;4506-4510.
153. Wisniewski K. E., Wisniewski H. M., Wen G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:1985;278-282.
154. Woolf N. J., Butcher L. L. Cholinergic projections to the basolateral amygdala A combined Evans Blue and acetylcholinesterase analysis . Brain Res. Bull. 8:1982;751-763.
155. Yankner B. A., Caceres A., Duffy L. K. Nerve growth factor potentiates the neurotoxicity of β-amyloid. Proc. Natl. Acad. Sci. USA. 87:1990;9020-9023.
156. Yankner B. A., Dawes L. R., Fisher S., Villa-Komaroff L., Oster-Granite M. L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:1989;417-420.
157. Yankner B. A., Duffy L. K., Kirschner D. A. Neurotrophic and neurotoxic effects of amyloid β-protein Reversal by tachykinin neuropeptides . Science. 250:1990;279-282.